[Evaluation for medical management on catamenial pneumothorax].

T. Hasumi, F. Hoshi, Y. Saito, R. Tanaka, Y. Ishiki

Research output: Contribution to journalArticlepeer-review

3 Citations (Scopus)


Catamenial pneumothorax (CP) is one of the clinical manifestations of endometriosis, therefore the systemic hormonal therapy is indispensable and should be the 1st choice for CP treatment. However, it is refractory and repeats a recurrence, so that a combined or sequential adjuvant treatment becomes necessary. From 2003 to 2009, 5 patients with CP were treated at our institution. All patients had right-sided pneumothorax and the history of pelvic endometriosis. By thoracoscopic examination, diaphragmatic abnormalities, such as defect, pinhole, or brown spot, were identified in all patients. We performed hormonal therapy combined with chemical pleurodesis using OK-432, as an initial treatment. Two patients have been free of recurrence for 24 and 53 months, respectively. Three patients who refused or interrupted hormonal therapy caused a recurrence, but were successfully managed with the addition of pleurodesis and continuing hormonal therapy. At present, all patients are asymptomatic with 13 to 92 months recurrence-free period. From the long-term results, our therapeutic strategy consisted of hormonal therapy and chemical pleurodesis is considered appropriate.

Original languageEnglish
Pages (from-to)374-379
Number of pages6
JournalKyobu geka. The Japanese journal of thoracic surgery
Issue number5
Publication statusPublished - 2012 May
Externally publishedYes

ASJC Scopus subject areas

  • Medicine(all)


Dive into the research topics of '[Evaluation for medical management on catamenial pneumothorax].'. Together they form a unique fingerprint.

Cite this